AMPA receptor subunit 1 (GluR‐A) knockout mice model the glutamate hypothesis of depression
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Recent evidence indicates that glutamate homeostasis and neurotransmission are altered in major depressive disorder, but the nature of the disruption and the mechanisms by which it contributes to the syndrome are unclear. Glutamate can act via AMPA, NMDA, or metabotropic receptors. Using targeted mutagenesis, we demonstrate here that mice with deletion of the main AMPA receptor subunit GluR‐A represent a depression model with good face and construct validity, showing behavioral and neurochemical features of depression also postulated for human patients. GluR‐A −/− mice display increased learned helplessness, decreased serotonin and norepinephrine levels, and disturbed glutamate ho‐meostasis with increased glutamate levels and increased NMDA receptor expression. These results correspond well with current concepts regarding the role of AMPA and NMDA receptors in depression, postulating that compounds that augment AMPA receptor signaling or decrease NMDA receptor functions have antidepressant effects. GluR‐A −/− mice represent a model to investigate the pathophysiology underlying the depressive phenotype and to identify changes in neural plasticity and resilience evoked by the genetic alterations in glutamatergic function. Furthermore, GluR‐A −/− mice may be a valuable tool to study biological mechanisms of AMPA receptor modulators and the efficacy of NMDA antagonists in reducing behavioral or biochemical changes that correlate with increased helplessness.—Chourbaji, S., Vogt, M. A., Fumagalli, F., Sohr, R., Frasca, A., Brandwein, C, Hörtnagl, H., Riva, M. A., Sprengel, R., Gass, P. AMPA receptor subunit 1 (GluR‐A) knockout mice model the glutamate hypothesis of depression. FASEB J. 22, 3129–3134 (2008)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Global deletion of the gene for the GluA1 subunit of the AMPAR, for example, results in a depressionlike phenotype in the learned helplessness test [113].”
From Plasticity of synapses and reward circuit function in the genesis and treatment of depression (2023) · cites this paper as [113]
Citations
Cites
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression
Shirayama, Y., Chen, A. C.-H., Nakagawa, S., Russell, D. S., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03251.2002 · Cited by 1,654
The ascent of mouse: advances in modelling human depression and anxiety
Cryan, J. F., & Holmes, A. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1825 · Cited by 1,198 · cited 1×
“Rodent models can provide important tools for elucidating the pathophysiology of psychiatric diseases (10).”
Maeng, S., Zarate, C. A., Du, J., Schloesser, R. J., McCammon, J., Chen, G., & Manji, H. K. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.028 · Cited by 1,103
Plasticity of the Hippocampus: Adaptation to Chronic Stress and Allostatic Load
McEwen, B. S. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb05830.x · Cited by 873
Subtype-Specific Alterations of γ-Aminobutyric Acid and Glutamatein Patients With Major Depression
Sanacora, G., Gueorguieva, R., Epperson, C. N., Wu, Y.-T., Appel, M., Rothman, D. L., Krystal, J. H., & Mason, G. F. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.7.705 · Cited by 796
Importance of AMPA Receptors for Hippocampal Synaptic Plasticity But Not for Spatial Learning
Zamanillo, D., Sprengel, R., Hvalby, Ø., Jensen, V., Burnashev, N., Rozov, A., Kaiser, K. M. M., Köster, H. J., Borchardt, T., Worley, P., et al. (1999) · Science · doi:10.1126/science.284.5421.1805 · Cited by 791 · cited 3×
“for synaptic plasticity in the hippocampus, a limbic structure important for emotional behavior ( 11 ).”
BackgroundResultInfluentialSelf-citationFunctional antagonists at the NMDA receptor complex exhibit antidepressant actions
Trullas, R., & Skolnick, P. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90204-j · Cited by 785 · cited 1×
“The results of our hypothesis-directed approach also correspond well with current concepts regarding the role of AMPA and NMDA receptors in antidepressive therapy, postulating that compounds that augment AMPA receptor signaling or that decrease NMDA receptor functions have antidepressant effects (8, 9, 24 , 26).”
ResultThe Yin and Yang of NMDA receptor signalling
Hardingham, G. E., & Bading, H. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)00040-1 · Cited by 620
DETERMINATION OF CATECHOLAMINES IN RAT BRAIN PARTS BY REVERSE‐PHASE ION‐PAIR LIQUID CHROMATOGRAPHY
Felice, L. J., Felice, J. D., & Kissinger, P. T. (1978) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1978.tb06573.x · Cited by 580
Research works printed but not linked: 1
- 10.1016/s0278-5846(84)80032-9 · doi:10.1016/s0278-5846(84)80032-9 · Paper page
Cited by
The neurobiology of depression and antidepressant action
Willner, P., Scheel-Krüger, J., & Belzung, C. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.12.007 · Cited by 519
Neural Mechanisms of Stress Resilience and Vulnerability
Franklin, T. B., Saab, B. J., & Mansuy, I. M. (2012) · Neuron · doi:10.1016/j.neuron.2012.08.016 · Cited by 500
Neuroinflammation and comorbidity of pain and depression
Walker, A. K., Kavelaars, A., Heijnen, C. J., & Dantzer, R. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008144 · Cited by 460
“These changes were associated with altered glutamatergic function and increased NMDA receptor expression (Chourbaji et al., 2008).”
BackgroundMcEwen, B. S., Chattarji, S., Diamond, D. M., Jay, T. M., Reagan, L. P., Svenningsson, P., & Fuchs, E. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.80 · Cited by 406
“Chourbaji S, Vogt MA, Fumagalli F, Sohr R, Frasca A, Brandwein C, Hortnagl H, Riva MA, Sprengel R, Gass P. AMPA receptor subunit 1 (GluR-A) knockout mice model the glutamate hypothesis of depression.”
BackgroundEmerging role of glutamate in the pathophysiology of major depressive disorder
Hashimoto, K. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.05.005 · Cited by 381
Mathew, S. J., Murrough, J. W., aan het Rot, M., Collins, K. A., Reich, D. L., & Charney, D. S. (2010) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709000169 · Cited by 294
Neuroplasticity Underlying the Comorbidity of Pain and Depression
Doan, L., Manders, T., & Wang, J. (2015) · Neural Plasticity · doi:10.1155/2015/504691 · Cited by 282
Ketamine and the next generation of antidepressants with a rapid onset of action
Machado-Vieira, R., Salvadore, G., DiazGranados, N., & Zarate, C. A. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.02.010 · Cited by 276
Discovering imaging endophenotypes for major depression
Hasler, G., & Northoff, G. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.23 · Cited by 274
An excitatory synapse hypothesis of depression
Thompson, S. M., Kallarackal, A. J., Kvarta, M. D., Van Dyke, A. M., LeGates, T. A., & Cai, X. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.03.003 · Cited by 265
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Inserra, A., De Gregorio, D., & Gobbi, G. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000056 · Cited by 232
Glutamatergic Modulators: The Future of Treating Mood Disorders?
Zarate, C., Machado-Vieira, R., Henter, I., Ibrahim, L., Diazgranados, N., & Salvadore, G. (2010) · Harvard Review of Psychiatry · doi:10.3109/10673229.2010.511059 · Cited by 228
Mathews, D. C., Henter, I. D., & Zarate, C. A. (2012) · Drugs · doi:10.2165/11633130-000000000-00000 · Cited by 220
“In addition, compounds that augment AMPA receptor signalling or decrease NMDA receptor function may have antidepressant effects.([81]) Further evidence of AMPA’s role in mood disorders comes from studies of medications with antidepressant properties that significantly enhance GluR1 and GluR2 expression in a dose-depen…”
BackgroundPham, T. H., & Gardier, A. M. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.02.017 · Cited by 186
“…rmthera.2019.02.017 and disturbed glutamate homeostasis with increased glutamate tissue levels and increased NMDA-R GluN1 subunit expression (Chourbaji et al., 2008), thus indicating a particular interaction between GluA1 and several neurotransmitter systems in provoking depression-like…”
BackgroundInfluentialCai, X., Kallarackal, A. J., Kvarta, M. D., Goluskin, S., Gaylor, K., Bailey, A. M., Lee, H.-K., Huganir, R. L., & Thompson, S. M. (2013) · Nature Neuroscience · doi:10.1038/nn.3355 · Cited by 180
“We found that induction of serotonin-mediated potentiation was abnormally enhanced and prolonged after CUS and that GluA1 S831A mice, like GluA1 −/− mice 48 , displayed a depressive-like phenotype.”
Li, M.-X., Zheng, H.-L., Luo, Y., He, J.-G., Wang, W., Han, J., Zhang, L., Wang, X., Ni, L., Zhou, H.-Y., et al. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.76 · Cited by 163
Clinically Significant Drug Interactions with Newer Antidepressants
Spina, E., Trifirò, G., & Caraci, F. (2012) · CNS Drugs · doi:10.2165/11594710-000000000-00000 · Cited by 160
Learned helplessness: unique features and translational value of a cognitive depression model
Vollmayr, B., & Gass, P. (2013) · Cell and Tissue Research · doi:10.1007/s00441-013-1654-2 · Cited by 155
Self-citationGoffer, Y., Xu, D., Eberle, S. E., D'amour, J., Lee, M., Tukey, D., Froemke, R. C., Ziff, E. B., & Wang, J. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2454-13.2013 · Cited by 141
Neurobiological Mechanisms of Stress Resilience and Implications for the Aged Population
Faye, C., McGowan, J. C., Denny, C. A., & David, D. J. P. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666170818095105 · Cited by 152
Alcaro, A., Panksepp, J., Witczak, J., Hayes, D. J., & Northoff, G. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.11.023 · Cited by 144
Bipolar disorder: from genes to behavior pathways
Martinowich, K., Schloesser, R. J., & Manji, H. K. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37703 · Cited by 124
Wang, H.-T., Huang, F., Hu, Z., Zhang, W., Qiao, X., Huang, Y., Dai, R., Li, F., & Li, C.-Q. (2017) · Neurotoxicity Research · doi:10.1007/s12640-016-9696-3 · Cited by 134
Emerging Evidence for the Widespread Role of Glutamatergic Dysfunction in Neuropsychiatric Diseases
McGrath, T., Baskerville, R., Rogero, M. M., & Castell, L. M. (2022) · Nutrients · doi:10.3390/nu14050917 · Cited by 135
Targeting Glutamatergic Signaling for the Development of Novel Therapeutics for Mood Disorders
Machado-Vieira, R., Salvadore, G., Ibrahim, L., Diaz-Granados, N., & Zarate Jr., C. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788168010 · Cited by 118
Chourbaji, S., Brandwein, C., & Gass, P. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.07.003 · Cited by 122
Self-citationRoles of glutamate signaling in preclinical and/or mechanistic models of depression
Tokita, K., Yamaji, T., & Hashimoto, K. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.04.016 · Cited by 111
Channelopathies linked to plasma membrane phosphoinositides
Logothetis, D. E., Petrou, V. I., Adney, S. K., & Mahajan, R. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-010-0828-y · Cited by 96
Freudenberg, F., Celikel, T., & Reif, A. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.03.005 · Cited by 105
Xu, X., Hong, X., Xie, L., Li, T., Yang, Y., Zhang, Q., Zhang, G., & Liu, X. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2012.08.005 · Cited by 104
From synapse to nucleus: Novel targets for treating depression
Covington, H. E., Vialou, V., & Nestler, E. J. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.12.004 · Cited by 98
Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm
Farley, S., Apazoglou, K., Witkin, J. M., Giros, B., & Tzavara, E. T. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709991076 · Cited by 96
Ketamine and other potential glutamate antidepressants
Dutta, A., McKie, S., & Deakin, J. F. W. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.10.028 · Cited by 98
Pollak, T. A., Beck, K., Irani, S. R., Howes, O. D., David, A. S., & McGuire, P. K. (2016) · Psychopharmacology · doi:10.1007/s00213-015-4156-y · Cited by 71
Barkus, C., Feyder, M., Graybeal, C., Wright, T., Wiedholz, L., Izquierdo, A., Kiselycznyk, C., Schmitt, W., Sanderson, D. J., Rawlins, J. N. P., et al. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.06.005 · Cited by 82
Self-citationSchmidt, M. V., Trümbach, D., Weber, P., Wagner, K., Scharf, S. H., Liebl, C., Datson, N., Namendorf, C., Gerlach, T., Kühne, C., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4668-10.2010 · Cited by 91
“Accordingly, mice lacking the GluR1 subunit, thus with a relatively higher GluR2-to-GluR1 ratio, have recently been postulated as a model of depression (Chourbaji et al., 2008).”
BackgroundPochwat, B., Szewczyk, B., Sowa-Kucma, M., Siwek, A., Doboszewska, U., Piekoszewski, W., Gruca, P., Papp, M., & Nowak, G. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001089 · Cited by 82
Does gene deletion of AMPA GluA1 phenocopy features of schizoaffective disorder?
Fitzgerald, P. J., Barkus, C., Feyder, M., Wiedholz, L. M., Chen, Y.-C., Karlsson, R.-M., Machado-Vieira, R., Graybeal, C., Sharp, T., Zarate, C., et al. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.08.005 · Cited by 80
Self-citationChao, H.-W., Tsai, L.-Y., Lu, Y.-L., Lin, P.-Y., Huang, W.-H., Chou, H.-J., Lu, W.-H., Lin, H.-C., Lee, P.-T., & Huang, Y.-S. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.3043-13.2013 · Cited by 80
Insulin-like growth factor 2 mitigates depressive behavior in a rat model of chronic stress
Luo, Y., Xu, Y., Cao, W.-Y., Zhong, X., Duan, J., Wang, X., Hu, Z., Li, F., Zhang, J.-Y., Zhou, M., et al. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.011 · Cited by 78
Tomasetti, C., Iasevoli, F., Buonaguro, E., De Berardis, D., Fornaro, M., Fiengo, A., Martinotti, G., Orsolini, L., Valchera, A., Di Giannantonio, M., et al. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010135 · Cited by 71
Marsden, W. N. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.06.021 · Cited by 73
Agmatine produces antidepressant-like effects by activating AMPA receptors and mTOR signaling
Neis, V. B., Moretti, M., Bettio, L. E. B., Ribeiro, C. M., da Rosa, P. B., Gonçalves, F. M., Lopes, M. W., Leal, R. B., & Rodrigues, A. L. S. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.03.009 · Cited by 71
Lima‐Ojeda, J. M., Vogt, M. A., Pfeiffer, N., Dormann, C., Köhr, G., Sprengel, R., Gass, P., & Inta, D. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.04.017 · Cited by 69
Self-citationInvolvement of pGluR1, EAAT2 and EAAT3 in offspring depression induced by prenatal stress
Zhang, X., Jia, N., Zhao, X. Y., Tang, G. K., Guan, L. X., Wang, D., Sun, H., Li, H., & Zhu, Z. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.031 · Cited by 65
Ismail, V., Zachariassen, L. G., Godwin, A., Sahakian, M., Ellard, S., Stals, K. L., Baple, E. L., Brown, K. T., Foulds, N. C., Wheway, G., et al. (2022) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2022.05.009 · Cited by 59
Rhythm and mood: Relationships between the circadian clock and mood-related behavior.
Schnell, A., Albrecht, U., & Sandrelli, F. (2014) · Behavioral Neuroscience · doi:10.1037/a0035883 · Cited by 51
Persistent pain alters AMPA receptor subunit levels in the nucleus accumbens
Su, C. H., D’amour, J. A., Lee, M. S., Lin, H.-Y., Manders, T. R., Xu, D., Eberle, S. E., Goffer, Y., Zou, A., Rahman, M., et al. (2015) · Molecular Brain · doi:10.1186/s13041-015-0140-z · Cited by 55
SOUSA, R. T. D., Loch, A. A., Carvalho, A. F., Brunoni, A. R., Haddad, M. R., Henter, I. D., Zarate, C. A., & Machado‐Vieira, R. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.149 · Cited by 52
Procaccini, C., Aitta‐aho, T., Jaako, K., Zharkovsky, A., Panhelainen, A. E., Sprengel, R., Linden, A.-M., & Korpi, E. R. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07485.x · Cited by 52
Self-citationThe dose makes the poison: From glutamate-mediated neurogenesis to neuronal atrophy and depression
Rubio-Casillas, A., & Fernández-Guasti, A. (2016) · Reviews in the Neurosciences · doi:10.1515/revneuro-2015-0066 · Cited by 49
“Mice with deletion of the main AMPAR subunit (GluR-A) display increased learned helplessness, decreased serotonin and norepinephrine levels, as well as disturbed glutamate homeostasis: increased glutamate levels and increased NMDAR expression (Chourbaji et al., 2008).”
BackgroundA novel hypothesis for COVID-19 pathogenesis: Retinol depletion and retinoid signaling disorder
Sarohan, A. R., Kızıl, M., İnkaya, A. Ç., Mahmud, S. O., Akram, M., & Çen, O. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110121 · Cited by 49
Gibbons, A. S., Brooks, L., Scarr, E., & Dean, B. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.10.001 · Cited by 41
Impact of Actin Filament Stabilization on Adult Hippocampal and Olfactory Bulb Neurogenesis
Kronenberg, G., Gertz, K., Baldinger, T., Kirste, I., Eckart, S., Yildirim, F., Ji, S., Heuser, I., Schröck, H., Hörtnagl, H., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4231-09.2010 · Cited by 45
Self-citationJiang, C., Lin, W.-J., Labonté, B., Tamminga, C. A., Turecki, G., Nestler, E. J., Russo, S. J., & Salton, S. R. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-018-0277-4 · Cited by 43
Ketamine: The final frontier or another depressing end?
Sial, O. K., Parise, E. M., Parise, L. F., Gnecco, T., & Bolaños‐Guzmán, C. A. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112508 · Cited by 45
Andreasen, J. T., Gynther, M., Rygaard, A., Bøgelund, T., Nielsen, S. D., Clausen, R. P., Mogensen, J., & Pickering, D. S. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.04.045 · Cited by 42
Amiri, S., Alijanpour, S., Tirgar, F., Haj‐Mirzaian, A., Amini-Khoei, H., Rahimi-Balaei, M., Rastegar, M., Ghaderi, M., Ghazi‐Khansari, M., & Zarrindast, M. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.05.003 · Cited by 41
Plasticity of synapses and reward circuit function in the genesis and treatment of depression
Thompson, S. M. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-022-01422-1 · Cited by 40
“Global deletion of the gene for the GluA1 subunit of the AMPAR, for example, results in a depressionlike phenotype in the learned helplessness test [113].”
BackgroundWang, C., Zhao, C., Liu, W., Huang, X., Deng, Y., Jiang, J., & Li, W. (2019) · Journal of Neurotrauma · doi:10.1089/neu.2019.6460 · Cited by 40
Katsouli, S., Stamatakis, A., Giompres, P., Kouvelas, E. D., Stylianopoulou, F., & Mitsacos, A. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.10.073 · Cited by 39
Biedermann, S. V., Weber‐Fahr, W., Zheng, L., Hoyer, C., Vollmayr, B., Gass, P., Ende, G., & Sartorius, A. (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.580778 · Cited by 37
Self-citationInta, D., Vogt, M. A., Elkin, H., Weber, T., Lima‐Ojeda, J. M., Schneider, M., Luoni, A., Riva, M. A., Gertz, K. R., Hellmann‐Regen, J., et al. (2013) · Hippocampus · doi:10.1002/hipo.22236 · Cited by 36
Self-citationDietary magnesium restriction reduces amygdala–hypothalamic GluN1 receptor complex levels in mice
Ghafari, M., Whittle, N., Miklósi, A. G., Kotlowsky, C., Schmuckermair, C., Berger, J., Bennett, K. L., Singewald, N., & Lübec, G. (2014) · Brain Structure and Function · doi:10.1007/s00429-014-0779-8 · Cited by 34
Weber, T., Vogt, M. A., Gartside, S. E., Berger, S. M., Luján, R., Lau, T., Herrmann, E., Sprengel, R., Bartsch, D., & Gass, P. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.332 · Cited by 34
Self-citationGluA4 facilitates cerebellar expansion coding and enables associative memory formation
Kita, K., Albergaria, C., Machado, A. S., Carey, M. R., Müller, M., & Delvendahl, I. (2021) · eLife · doi:10.7554/elife.65152 · Cited by 33
Molecular and cellular dissection of NMDA receptor subtypes as antidepressant targets
Lang, E., Mallien, A. S., Vasilescu, A.-N., Hefter, D., Luoni, A., Riva, M. A., Borgwardt, S., Sprengel, R., Lang, U. E., Gass, P., et al. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.08.012 · Cited by 33
Self-citationO’Tuathaigh, C. M. P., & Waddington, J. L. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.01.016 · Cited by 32
van Zyl, P. J., Dimatelis, J. J., & Russell, V. A. (2015) · Metabolic Brain Disease · doi:10.1007/s11011-015-9757-y · Cited by 33
Antidepressant treatments-induced modifications of glutamatergic transmission in rat frontal cortex.
Bobula, B., & Hess, G. (2008) · PubMed · Cited by 32
Freudenberg, F., Resnik, E., Kolleker, A., Celikel, T., Sprengel, R., & Seeburg, P. H. (2016) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2016.07.005 · Cited by 31
Self-citationMachado‐Vieira, R., & Zarate, C. A. (2011) · Depression and Anxiety · doi:10.1002/da.20800 · Cited by 30
Procaccini, C., Maksimovic, M., Aitta‐aho, T., Korpi, E. R., & Linden, A.-M. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.07.010 · Cited by 28
Fumagalli, F., Pasini, M., Sartorius, A., Scherer, R., Racagni, G., Riva, M. A., & Gass, P. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000544 · Cited by 28
Self-citationAn Update on the Basic and Clinical Science of Ketamine Analgesia
Doan, L., & Wang, J. (2018) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000000635 · Cited by 27
Antidepressant-like effect of guanosine involves activation of AMPA receptor and BDNF/TrkB signaling
da Rosa, P. B., Bettio, L. E. B., Neis, V. B., Moretti, M., Kaufmann, F. N., Tavares, M. K., Werle, I., Dalsenter, Y. D. O., Platt, N., Rosado, A. F., et al. (2021) · Purinergic Signalling · doi:10.1007/s11302-021-09779-6 · Cited by 27
Are you real? Visual simulation of social housing by mirror image stimulation in single housed mice
Fuß, J., Richter, S. H., Steinle, J., Deubert, G., Hellweg, R., & Gass, P. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.01.015 · Cited by 25
Self-citationGordillo-Salas, M., Pilar-Cuéllar, F., Auberson, Y. P., & Adell, A. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0131-9 · Cited by 25
Grape‐derived polyphenols produce antidepressant effects via VGF‐ and BDNF‐dependent mechanisms
Jiang, C. S., Sakakibara, E., Lin, W., Wang, J., Pasinetti, G. M., & Salton, S. R. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14098 · Cited by 25
Yao, H., Shen, H., Yu, H. Q., Wang, C., Ding, R., Lan, X., Tash, D., Wu, X., Wang, X., & Zhang, G. (2021) · Physiology & Behavior · doi:10.1016/j.physbeh.2021.113387 · Cited by 25
Liu, C., Zhang, L., Wu, J., Sui, X., Xu, Y., Huang, L., Han, Y., Zhu, H., Li, Y., Sun, X., et al. (2017) · Experimental Brain Research · doi:10.1007/s00221-017-5056-7 · Cited by 25
Chronic restraint stress impairs cognition via modulating HDAC2 expression
Wu, J., Liu, C., Zhang, L., He, B., Shi, W.-P., Shi, H., & Qin, C. (2021) · Translational Neuroscience · doi:10.1515/tnsci-2020-0168 · Cited by 24
Fumagalli, F., Calabrese, F., Luoni, A., Shahid, M., Racagni, G., & Riva, M. A. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.10.004 · Cited by 24
Self-citationRéus, G. Z., Stringari, R. B., Rezin, G. T., Fraga, D. B., Daufenbach, J. F., Scaini, G., Benedet, J., Rochi, N., Streck, E. L., & Quevedo, J. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-011-0718-2 · Cited by 23
“…(NMDA) receptor (such as, ketamine and memantine) have antidepressant effects in animal models of depression and in humans (Réus et al. 2010; Chourbaji et al. 2008; Feyissa et al. 2009; Garcia et al. 2008a, b; Phelps et al. 2009; Zarate and Manji 2008; Liebrenz et al. 2007; Ferguson and…”
BackgroundAMPA GluR‐A receptor subunit mediates hippocampal responsiveness in mice exposed to stress
Fumagalli, F., Caffino, L., Vogt, M. A., Frasca, A., Racagni, G., Sprengel, R., Gass, P., & Riva, M. A. (2010) · Hippocampus · doi:10.1002/hipo.20817 · Cited by 23
Self-citationThe Ampa Receptor as a Therapeutic Target: Current Perspectives and Emerging Possibilities
Mellor, I. R. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.27 · Cited by 22
Freudenberg, F., Marx, V., Mack, V., Layer, L. E., Klugmann, M., Seeburg, P. H., Sprengel, R., & Celikel, T. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.12.003 · Cited by 21
Self-citationVasilescu, A.-N., Schweinfurth, N., Borgwardt, S., Gass, P., Lang, U. E., Inta, D., & Eckart, S. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s119004 · Cited by 21
Self-citationMolecular Mechanism of Congenital Heart Disease and Pulmonary Hypertension
Nakanishi, T., Baldwin, H. S., Fineman, J. R., & Yamagishi, H. (2020) · Springer eBooks · doi:10.1007/978-981-15-1185-1 · Cited by 21
Vogt, M. A., Elkin, H., Pfeiffer, N., Sprengel, R., Gass, P., & Inta, D. (2014) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-014-0509-5 · Cited by 20
Self-citationAitta‐aho, T., Maksimovic, M., Dahl, K., Sprengel, R., & Korpi, E. R. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00309 · Cited by 19
Self-citationIntracellular Signaling Cascades in Bipolar Disorder
Jones, G. H., Rong, C., Shariq, A. S., Mishra, A. P., & Machado‐Vieira, R. (2020) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_157 · Cited by 19
Yao, H., Zhang, D., Yu, H., Shen, H., Lan, X., Liu, H., Chen, X., Wu, X., Zhang, G., & Wang, X. (2022) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.115924 · Cited by 19
Liu, B., Du, Y., Xu, C. S., Liu, Q., & Zhang, L. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148375 · Cited by 19
Lu, Y., Zhang, J., Zhang, L., Dang, S., Su, Q., Zhang, H., Lin, T., Zhang, X., Zhang, Y., Sun, H., et al. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2393-7 · Cited by 19
Distinct regulation of brain-derived neurotrophic factor and noradrenaline in S100B knockout mice
Schulte‐Herbrüggen, O., Hörtnagl, H., Ponath, G. D., Rothermundt, M., & Hellweg, R. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.07.013 · Cited by 17
Self-citationMallien, A. S., Pfeiffer, N., Brandwein, C., Inta, D., Sprengel, R., Palme, R., Talbot, S. R., & Gass, P. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.908366 · Cited by 16
Self-citationLerch, S., Brandwein, C., Dormann, C., Gass, P., & Chourbaji, S. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.08.021 · Cited by 16
Self-citationAbnormal 5-HT modulation of stress behaviors in the Kv4.2 knockout mouse
Lockridge, A. D., Su, J., & Yuan, L. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.08.047 · Cited by 15
Inta, D., Vogt, M. A., Pfeiffer, N., Köhr, G., & Gass, P. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.03.036 · Cited by 15
Self-citation
Metadata
- Authors
- Chourbaji, S., Vogt, M. A., Fumagalli, F., Sohr, R., Frasca, A., Brandwein, C., Hörtnagl, H., Riva, M. A., Sprengel, R., & Gass, P.
- Affiliations
- Heidelberg University (DE)
- University of Milan (IT)
- Charité – Universitätsmedizin Berlin (DE)
- Max Planck Society (DE)
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2008-05-20
- Volume
- 22
- Issue
- 9
- Pages
- 3129-3134
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W1984754469
- Cited by
- 144
- References
- 36
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 4 · 2023: 3 · 2022: 11 · 2021: 6 · 2020: 7 · 2019: 6 · 2018: 7 · 2017: 8 · 2016: 9 · 2015: 11 · 2014: 9 · 2013: 15 · 2012: 6
- FWCI
- 8.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Max Planck Digital Library (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (GA427/8–1, SP602/ 2–1)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- AMPA receptors, knockout mice, depression model, glutamate homeostasis, NMDA receptor, learned helplessness, serotonin, norepinephrine, antidepressant mechanism, NMDA receptor antagonists, neuroplasticity, resilience
- MeSH terms
- Animals, Major Depressive Disorder, Disease Models, Animal, Helplessness, Learned, Hippocampus, Male, Norepinephrine, Serotonin, Receptors, N-Methyl-D-Aspartate, Receptors, AMPA, Mice, Knockout, Glutamic Acid, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.